Abstract
The drug discovery process mainly relies on the experimental high-throughput screening of huge compound libraries in their pursuit of new active compounds. However, spiraling research and development costs and unimpressive success rates have driven the development of more rational, efficient, and cost-effective methods. With the increasing availability of protein structural information, advancement in computational algorithms, and faster computing resources, in silico docking-based methods are increasingly used to design smaller and focused compound libraries in order to reduce screening efforts and costs and at the same time identify active compounds with a better chance of progressing through the optimization stages. This chapter is a primer on the various docking-based methods developed for the purpose of structure-based library design. Our aim is to elucidate some basic terms related to the docking technique and explain the methodology behind several docking-based library design methods. This chapter also aims to guide the novice computational practitioner by laying out the general steps involved for such an exercise. Selected successful case studies conclude this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mayr, L. M., Fuerst, P. (2008) The future of high-throughput screening. J Biomol Screen 13, 443–448.
Entzeroth, M. (2003) Emerging trends in high-throughput screening. Curr Opin Pharmacol 3, 522–529.
Schnecke, V., Bostrom, J. (2006) Computational chemistry-driven decision making in lead generation. Drug Discov Today 11, 43–50.
Boldt, G. E., Dickerson, T. J., Janda, K. D. (2006) Emerging chemical and biological approaches for the preparation of discovery libraries. Drug Discov Today 11, 143–148.
Bohacek, R. S., McMartin, C., Guida, W. C. (1996) The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 16, 3–50.
Walters, W. P., Stahl M. T., Murcko, M. A. (1998) Virtual screening – an overview. Drug Discov Today 3, 160–178.
Phatak, S. S., Stephan, C. C., Cavasotto, C. N. (2009) High-throughput and in silico screenings in drug discovery. Expert Opin. Drug Discov 4, 947–959.
Keseru, G. M., Makara, G. M. (2006) Hit discovery and hit-to-lead approaches. Drug Discov Today 11, 741–748.
Macarron, R. (2006) Critical review of the role of HTS in drug discovery. Drug Discov Today 11, 277–279.
Fox, S., Farr-Jones, S., Sopchak, L., Boggs, A., Nicely, H. W., Khoury, R., Biros, M. (2006) High-throughput screening: update on practices and success. J Biomol Screen 11, 864–869.
Keseru, G. M., Makara, G. M. (2009) The influence of lead discovery strategies on the properties of drug candidates. Nat Rev Drug Discov 8, 203–212.
Lipkin, M. J., Stevens, A. P., Livingstone, D. J., Harris, C. J. (2008) How large does a compound screening collection need to be? Comb Chem High Throughput Screening 11, 482–493.
Nestler, H. P. (2005) Combinatorial chemistry and fragment screening – Two unlike siblings? Curr Drug Discov Tech 2, 1–12.
Diller, D. J., Merz, K. M., Jr. (2001) High throughput docking for library design and library prioritization. Proteins 43, 113–124.
Decornez, H., Gulyas-Forro, A., Papp, A., Szabo, M., Sarmay, G., Hajdu, I., Cseh, S., Dorman, G., Kitchen, D. B. (2009) Design, selection, evaluation of a general kinase-focused library. ChemMedChem 4, 1273–1278.
Lipinski, C. A. (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44, 235–249.
Schnur, D. M. (2008) Recent trends in library design: ‘rational design’ revisited. Curr Opin Drug Discov Devel 11, 375–380.
Villar, H. O., Koehler, R. T. (2000) Comments on the design of chemical libraries for screening. Mol Divers 5, 13–24.
Manjasetty, B. A., Turnbull, A. P., Panjikar, S., Bussow, K., Chance, M. R. (2008) Automated technologies and novel techniques to accelerate protein crystallography for structural genomics. Proteomics 8, 612–625.
Gileadi, O., Knapp, S., Lee, W. H., Marsden, B. D., Muller, S., Niesen, F. H., Kavanagh, K. L., Ball, L. J., von Delft, F., Doyle, D. A., Oppermann, U. C., Sundstrom, M. (2007) The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins. J Struct Funct Genomics 8, 107–119.
Cavasotto, C. N., Phatak, S. S. (2009) Homology modeling in drug discovery: current trends and applications. Drug Discov Today 14, 676–683.
Cavasotto, C. N., Orry, A. J., Murgolo, N. J., Czarniecki, M. F., Kocsi, S. A., Hawes, B. E., O’Neill, K. A., Hine, H., Burton, M. S., Voigt, J. H., Abagyan, R. A., Bayne, M. L., Monsma, F. J., Jr. (2008) Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem 51, 581–588.
Hong, T. J., Park, H., Kim, Y. J., Jeong, J. H., Hahn, J. S. (2009) Identification of new Hsp90 inhibitors by structure-based virtual screening. Bioorg Med Chem Lett 19, 4839–4842.
Brozic, P., Turk, S., Lanisnik Rizner, T., Gobec, S. (2009) Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening. Mol Cell Endocrinol 301, 245–250.
Park, H., Bhattarai, B. R., Ham, S. W., Cho, H. (2009) Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors. Eur J Med Chem 44, 3280–3284.
Heinke, R., Spannhoff, A., Meier, R., Trojer, P., Bauer, I., Jung, M., Sippl, W. (2009) Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitors. ChemMedChem 4, 69–77.
Wang, Q., Wang, J., Cai, Z., Xu, W. (2008) Prediction of the binding modes between BB-83698 and peptide deformylase from Bacillus stearothermophilus by docking and molecular dynamics simulation. Biophys Chem 134, 178–184.
Padgett, L. W., Howlett, A. C., Shim, J. Y. (2008) Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor. J Mol Signal 3, 5.
Zampieri, D., Mamolo, M. G., Vio, L., Banfi, E., Scialino, G., Fermeglia, M., Ferrone, M., Pricl, S. (2007) Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P450(14DM) by molecular docking and MM/PBSA method. Bioorg Med Chem 15, 7444–7458.
Monti, M. C., Casapullo, A., Cavasotto, C. N., Napolitano, A., Riccio, R. (2007) Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation. Chembiochem 8, 1585–1591.
Diaz P., Phatak, S. S., Xu, J., Fronczek, F. R., Astruc-Diaz, F., Thompson, C. M., Cavasotto, C. N., Naguib, M. (2009) 2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling. ChemMedChem 4, 1615–1629.
Andricopulo, A. D., Salum, L. B., Abraham, D. J. (2009) Structure-based drug design strategies in medicinal chemistry. Curr Topics Med Chem 9, 777–790.
Cavasotto, C. N., Orry, A. J. (2007) Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem 7, 1006–1014.
Kitchen, D. B., Decornez, H., Furr, J. R., Bajorath, J. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3, 935–949.
Cavasotto, C. N., Ortiz, M. A., Abagyan, R. A., Piedrafita, F. J. (2006) In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells. Bioorg Med Chem Lett 16, 1969–1974.
Klebe, G. (2006) Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 11, 580–594.
Zoete, V., Grosdidier, A., Michielin, O. (2009) Docking, virtual high throughput screening and in silico fragment-based drug design. J Cell Mol Med 13, 238–248.
Marsden, R. L., Orengo, C. A. (2008) Target selection for structural genomics: an overview. Methods Mol Biol 426, 3–25.
Levitt, D. G., Banaszak, L. J. (1992) POCKET: a computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. J Mol Graph 10, 229–234.
Hendlich, M., Rippmann, F., Barnickel, G. (1997) LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J Mol Graph Model 15, 359–363, 389.
Laskowski, R. A. (1995) SURFNET: a program for visualizing molecular surfaces, cavities, intermolecular interactions. J Mol Graph 13, 323–330, 307–328.
Balakin, K. V., Kozintsev, A. V., Kiselyov, A. S., Savchuk, N. P. (2006) Rational design approaches to chemical libraries for hit identification. Curr Drug Discov Technol 3, 49–65.
Orry, A. J., Abagyan, R. A., Cavasotto, C. N. (2006) Structure-based development of target-specific compound libraries. Drug Discov Today 11, 261–266.
Brown, E. N., Ramaswamy, S. (2007) Quality of protein crystal structures. Acta Crystallogr D Biol Crystallogr 63, 941–950.
Davis, A. M., St-Gallay, S. A., Kleywegt, G. J. (2008) Limitations and lessons in the use of X-ray structural information in drug design. Drug Discov Today 13, 831–841.
Cavasotto, C. N., Singh, N. (2008) Docking and high throughput docking: successes and the challenge of protein flexibility. Curr Comput Aided Drug Design 4, 221–234.
Sousa, S. F., Fernandes, P. A., Ramos, M. J. (2006) Protein-ligand docking: current status and future challenges. Proteins 65, 15–26.
Li, Z., Lazaridis, T. (2007) Water at biomolecular binding interfaces. Phys Chem Chem Phys 9, 573–581.
Mancera, R. L. (2007) Molecular modeling of hydration in drug design. Curr Opin Drug Discov Devel 10, 275–280.
Corbeil, C. R., Moitessier, N. (2009) Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs. J Chem Inf Model 49, 997–1009.
Chen, J., Swamidass, S. J., Dou, Y., Bruand, J., Baldi, P. (2005) ChemDB: a public database of small molecules and related chemoinformatics resources. Bioinformatics 21, 4133–4139.
Irwin, J. J., Shoichet, B. K. (2005) ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 45, 177–182.
Williams, A. J. (2008) Public chemical compound databases. Curr Opin Drug Discov Develop 11, 393–404.
Drie, J. H. (2005) Pharmacophore-based virtual screening: a practical perspective, in (Alvarez, J., Shoichet, B., eds.) Virtual Screening in Drug Discovery. CRC Press, Boca Raton, FL, pp. 157–205.
Oprea, T. I., Bologa, C. G., Olah, M. M. (2005) Compound selection for virtual screening, in Virtual screening in Drug Discovery (Alvarez, J., Shoichet, B., eds.), CRC Press, Boca Raton, FL, pp. 89–106.
Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 23, 3–25.
Oprea, T. I. (2002) Current trends in lead discovery: are we looking for the appropriate properties? J Comput Aided Mol Des 16, 325–334.
Hubbard, R. E. (2008) Fragment approaches in structure-based drug discovery. J Synchrotron Radiat 15, 227–230.
Kroemer, R. T. (2007) Structure-based drug design: docking and scoring. Curr Protein Pept Sci 8, 312–328.
Barril, X., Hubbard, R. E., Morley, S. D. (2004) Virtual screening in structure-based drug discovery. Mini Rev Med Chem 4, 779–791.
Teague, S. J. (2003) Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2, 527–541.
B-Rao, C., Subramanian, J., Sharma, S. D. (2009) Managing protein flexibility in docking and its applications. Drug Discov Today 14, 394–400.
Dias, R., de Azevedo, W. F., Jr. (2008) Molecular docking algorithms. Curr Drug Targets 9, 1040–1047.
Sperandio, O., Miteva, M. A., Delfaud, F., Villoutreix, B. O. (2006) Receptor-based computational screening of compound databases: the main docking-scoring engines. Curr Protein Pept Sci 7, 369–393.
Stahl, M., Rarey, M. (2001) Detailed analysis of scoring functions for virtual screening. J Med Chem 44, 1035–1042.
Perola, E., Walters, W. P., Charifson, P. S. (2005) An analysis of critical factors affecting docking and scoring, in (Alvarez, J., Shoichet, B., eds.) Virtual screening in drug discovery. CRC Press, Boca Raton, FL, pp. 47–85.
Warren, G. L., Andrews, C. W., Capelli, A. M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., Tedesco, G., Wall, I. D., Woolven, J. M., Peishoff, C. E., Head, M. S. (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49, 5912–5931.
Waszkowycz, B. (2008) Towards improving compound selection in structure-based virtual screening. Drug Discov Today 13, 219–226.
Manallack, D. T., Pitt, W. R., Gancia, E., Montana, J. G., Livingstone, D. J., Ford, M. G., Whitley, D. C. (2002) Selecting screening candidates for kinase and G protein-coupled receptor targets using neural networks. J Chem Inf Comput Sci 42, 1256–1262.
Schneider, G. (2002) Trends in virtual combinatorial library design. Curr Med Chem 9, 2095–2101.
Beavers, M. P., Chen, X. (2002) Structure-based combinatorial library design: methodologies and applications. J Mol Graph Model 20, 463–468.
Coupez, B., Lewis, R. A. (2006) Docking and scoring–theoretically easy, practically impossible? Curr Med Chem 13, 2995–3003.
Sun, Y., Ewing, T. J., Skillman, A. G., Kuntz, I. D. (1998) CombiDOCK: structure-based combinatorial docking and library design. J Comput Aided Mol Des 12, 597–604.
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., Ferrin, T. E. (1982) A geometric approach to macromolecule-ligand interactions. J Mol Biol 161, 269–288.
Murray, C. W., Clark, D. E., Auton, T. R., Firth, M. A., Li, J., Sykes, R. A., Waszkowycz, B., Westhead, D. R., Young, S. C. (1997) PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology. J Comput Aided Mol Des 11, 193–207.
Blaney, J. M., Dixon, J. S. (1993) A good ligand is hard to find: automated docking methods. Perspect Drug Discov Des 1, 301–319.
Kuntz, I. D., Meng, E. C., Shoichet, B. (1994) Structure-based molecular design. Acc Chem Res 27, 117–123.
Bohm, H. J. (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des 8, 243–256.
Clark, D. E., Frenkel, D., Levy, S. A., Li, J., Murray, C. W., Robson, B., Waszkowycz, B., Westhead, D. R. (1995) PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des 9, 13–32.
Makino, S., Ewing, T. J., Kuntz, I. D. (1999) DREAM++: flexible docking program for virtual combinatorial libraries. J Comput Aided Mol Des 13, 513–532.
Roe, D. C., Kuntz, I. D. (1995) BUILDER v.2: improving the chemistry of a de novo design strategy. J Comput Aided Mol Des 9, 269–282.
Van Gunsteren, W. F., Berendsen, H. J. C. (1977) Algorithms for macromolecular dynamics and constraint dynamics. Mol Phys 34, 1311–1327.
Sprous, D. G., Lowis, D. R., Leonard, J. M., Heritage, T., Burkett, S. N., Baker, D. S., Clark, R. D. (2004) OptiDock: virtual HTS of combinatorial libraries by efficient sampling of binding modes in product space. J Comb Chem 6, 530–539.
Rarey, M., Lengauer, T. (2000) A recursive algorithm for efficient combinatorial library docking. Perspect Drug Discov Des 20, 63–81.
Zhou, J. Z., Shi, S., Na, J., Peng, Z., Thacher, T. (2009) Combinatorial library-based design with Basis Products. J Comput Aided Mol Des DOI 10.1007/s10822-009-9297-9.
Grzybowski, B. A., Ishchenko, A. V., Kim, C. Y., Topalov, G., Chapman, R., Christianson, D. W., Whitesides, G. M., Shakhnovich, E. I. (2002) Combinatorial computational method gives new picomolar ligands for a known enzyme. Proc Natl Acad Sci USA 99, 1270–1273.
Zhou, J. Z. (2008) Structure-directed combinatorial library design. Curr Opin Chem Biol 12, 379–385.
Head, M. S., Ryan, M. D., Lee, D., Feng, Y., Janson, C. A., Concha, N. O., Keller, P. M., deWolf, W. E., Jr. (2001) Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8. J Comput Aided Mol Des 15, 1105–1117.
Zhao, L., Huang, W., Liu, H., Wang, L., Zhong, W., Xiao, J., Hu, Y., Li, S. (2006) FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates. J Med Chem 49, 4059–4071.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Science+Business Media, LLC
About this protocol
Cite this protocol
Cavasotto, C.N., Phatak, S.S. (2011). Docking Methods for Structure-Based Library Design. In: Zhou, J. (eds) Chemical Library Design. Methods in Molecular Biology, vol 685. Humana Press. https://doi.org/10.1007/978-1-60761-931-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-931-4_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-930-7
Online ISBN: 978-1-60761-931-4
eBook Packages: Springer Protocols